Royal Oak Tribune
Volunteers sought for coronavirus vaccine trial
The Henry Ford Health System is recruiting volunteers for a COVID-19 vaccine trial that will begin immediately.
“We are honored to be one of only three sites in Michigan to participate in Phase 3 trials for Janssen’s COVID-19 vaccine candidate,” said Adnan Munkarah, M. D., Henry Ford Health System Executive Vice President and Chief Clinical Officer. “Henry Ford Health System has become a leader in treating COVID-19, as well as the study and development of potential vaccines and innovative therapeutics. We believe participating in this latest trial is an important part of our effort to stop this global pandemic.”
The Phase 3 randomized, double- blind, placebo- controlled clinical trial is designed to evaluate the safety and efficacy of a single vaccine dose of the Janssen COVID-19 vaccine candidate versus placebo. Approximately 60,000 adults across the United States and internationally will participate, including significant representation among study participants of people over age 60.
The trial will include people with and without comorbidities associated with an increased risk for progression to severe COVID-19. Researchers at Henry Ford Health System will enroll adults from Southeast Michigan, aged 18 or older. Visit the U.S. Clinical Trials website for more information about the inclusion and/or exclusion criteria of the Phase 3 ENSEMBLE clinical trial.
“We hope Southeast Michigan residents will consider taking part in the vaccine trial, particularly people who are at a higher risk of coming in contact with the virus, and people who have a higher likelihood developing severe symptoms,” said Dr. Munkarah.
People interested in volunteering can find details about the trial at www.henryford.com.